Vera Therapeutics, Inc.
VERA
$21.71
-$0.32-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.04% | 6.88% | -38.34% | -18.76% | -10.63% |
| Total Depreciation and Amortization | 54.55% | 129.17% | -98.39% | 13,490.91% | 175.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.09% | 27.36% | 199.92% | -59.29% | 22.42% |
| Change in Net Operating Assets | -1,196.43% | -112.42% | -4.57% | 171.28% | -315.37% |
| Cash from Operations | -38.85% | -6.23% | -48.84% | 26.75% | -34.55% |
| Capital Expenditure | 71.01% | -171.01% | -167.42% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 107.02% | -672.53% | 270.69% | 89.70% | -1,277.75% |
| Cash from Investing | 106.92% | -677.77% | 268.97% | 89.66% | -1,281.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.56% | 46,084.97% | -78.13% | -98.83% | 338,303.45% |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | -99.53% | 44,007.58% | -78.51% | -98.76% | 1,013.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -157.43% | 2,911.98% | 104.93% | -287.93% | 28.42% |